EVX Ventures is a global VC that builds, incubates, and invests in biotech companies. With a focus on disruptive therapeutics platform technologies and novel therapeutic modalities, we invest in global technologies to redefine the therapeutics of tomorrow. With offices across Boston, Singapore, and Beijing, we leverage our global networks to build cross-border ecosystems, nurture promising early-stage biotech startups, and create lasting and meaningful impact for patients. For more information, visit https://www.evx.ventures.
Location: Singapore
Employees: 11-50
Founded date: 2018
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 9
| Date | Name | Website | Total Raised | Location |
| 27.05.2024 | LERNA BIOP... | lernabio.com | - | - |
| 27.05.2024 | JOTBODY | jotbody.com | - | China, Hon... |
| 04.04.2023 | PairX Bio | pairxbio.com | - | Singapore |
| - | AltruBio | altrubio.com | $288M | - |
| - | Cargene Th... | cargene.com | $19.2M | Singapore |
| - | Carmine Th... | carminetherapeutics.com | - | United Sta... |
| - | CARCELL BI... | carcell.com | - | - |
| - | Nuevocor | nuevocor.com | $24M | - |
| - | Hummingbir... | hummingbirdbioscience.com | $169M | Singapore |
Mentions in press and media 8
| Date | Title | Description |
| 19.12.2022 | Carcell welcomes Prof. Harvey Lodish as Chair of its Scientific Advisory Board | SINGAPORE and SHANGHAI, Dec. 19, 2022 /PRNewswire/ -- Carcell Biopharma ("Carcell"), an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the Scientific Advisory Board. He joins Prof. Jianzhu Chen of... |
| 14.12.2021 | Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital | SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capi... |
| 14.12.2021 | Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital | SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capi... |
| 02.11.2021 | Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments | SINGAPORE, Nov. 2, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. The round was led by Hyfinity Investments, with participation from BioTrack ... |
| 18.06.2021 | Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies | SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed $24 million Series A financing round. The round was ... |
| 05.05.2021 | Carmine Therapeutics appoints Don Haut as CEO | |
| 05.05.2021 | Carmine Therapeutics : appoints Don Haut as CEO | CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don Haut, PhD has been appointed as its Chief Executive Officer, and member of the Board of Directors. Founde... |
| 05.05.2021 | Carmine Therapeutics appoints Don Haut as CEO | CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don Haut, PhD has been appointed as its Chief Executive Officer, and member of the Board of Directors. Founde... |